SAFETY AND EFFICACY OF DIRECT ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION AND VALVULAR HEART DISEASE

被引：0
|
作者：
Lippmann, Matthew [1 ]
Apte, Nachiket [1 ]
Pierpoline, Michael [1 ]
Taduru, Siva Sagar [1 ]
Dehkordi, Seyed Hamed Hosseini [1 ]
Isom, Nicholas [1 ]
Dalia, Tarun [1 ]
Hacker, Ethan [1 ]
Robinson, Alexander [1 ]
Buechler, Tyler [1 ]
Jazayeri, Mohammad-Ali [1 ]
Masoomi, Reza [1 ]
Sheldon, Seth [1 ]
Reddy, Madhu [1 ]
机构：
[1] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2019年 / 73卷 / 09期
关键词：
D O I：
10.1016/S0735-1097(19)31109-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1270-301
引用
收藏
页码：501 / 501
页数：1
相关论文
共 50 条
  • [1] Outcomes of Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Valvular Heart Disease
    Dawwas, Ghadeer K.
    Barnes, Geoffrey D.
    [J]. CURRENT CARDIOLOGY REPORTS, 2022, 24 (06) : 731 - 738
  • [2] Outcomes of Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Valvular Heart Disease
    Ghadeer K. Dawwas
    Geoffrey D. Barnes
    [J]. Current Cardiology Reports, 2022, 24 : 731 - 738
  • [3] Direct-acting oral anticoagulants in patients with atrial fibrillation and valvular heart disease
    Canales, Natalie
    Cao, Tina
    Fakourfar, Neeloufar
    Snee, Mara
    Tsu, Laura
    [J]. JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2022, 35 (09): : 17 - 18
  • [4] Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Lesions
    Di Biase, Luigi
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (02):
  • [5] Evaluation of the Safety and Effectiveness of Direct-Acting Oral Anticoagulants in Patients with Atrial Fibrillation and Coexisting Valvular Heart Disease
    Hampton, Meredith L.
    Tellor, Katie B.
    Armbruster, Anastasia L.
    Theodos, Gus
    Schwarze, Martin W.
    [J]. AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2020, 20 (06) : 611 - 617
  • [6] Evaluation of the Safety and Effectiveness of Direct-Acting Oral Anticoagulants in Patients with Atrial Fibrillation and Coexisting Valvular Heart Disease
    Meredith L. Hampton
    Katie B. Tellor
    Anastasia L. Armbruster
    Gus Theodos
    Martin W. Schwarze
    [J]. American Journal of Cardiovascular Drugs, 2020, 20 : 611 - 617
  • [7] Efficacy and safety of direct oral anticoagulants in patients with atrial fibrillation and chronic kidney disease
    Bhatia, Harpreet S.
    Bailey, Joseph
    Unlu, Ozan
    Hoffman, Katherine
    Kim, Robert J.
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2019, 42 (11): : 1463 - 1470
  • [8] Efficacy and Safety of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Chronic Kidney Disease
    Bhatia, Harpreet S.
    Bailey, Joseph
    Unlu, Ozan
    Kim, Robert J.
    [J]. CIRCULATION, 2018, 138
  • [9] Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Valvular Atrial Fibrillation
    Rodwin, Benjamin A.
    [J]. ANNALS OF INTERNAL MEDICINE, 2021, 174 (10) : 1488 - 1489
  • [10] Safety and Efficacy of Novel Oral Anticoagulants Versus Warfarin in Medicare Beneficiaries With Atrial Fibrillation and Valvular Heart Disease
    Briasoulis, Alexandros
    Inampudi, Chakradhari
    Akintoye, Emmanuel
    Alvarez, Paulino
    Panaich, Sidakpal
    Vaughan-Sarrazin, Mary
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (08):
12345